View Post

EMG data obtained from 35 ARSACS individuals

In News Archives by ARSACS

EMG data of 6 muscles from 35 ARSACS patients were obtained as part of Dr. Luc J. Hébert’s ARSACS research project. The analysis of these EMG data will help to better understand the problem of spasticity in ARSACS patients and could eventually open the door to new interventions targeted more on these neuro- locomotive deficiences. Interesting, right? Share with your …

View Post

Learning from the UNC Catalyst for Rare Diseases

In News Archives by ARSACS

The University of North Carolina (UNC) Catalyst for Rare Diseases, funded in 2016, was established as a precompetitive open research group with a mission to understand the functional phenotic manifestations of genetic mutations. This article describes the initial experiences and learning from the UNC Catalyst for Rare diseases. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez …

View Post

Invitation to Le Diner des Producteurs 2019

In News Archives by ARSACS

Invitation to join us at the 13th edition of the Diner des Producteurs, major annual fundraising event for the Ataxia Charlevoix-Saguenay Foundation. Discover the fine cuisine prepared by guest chef Pierre Gagnaire 3 Michelin stars, wines from La Maison E. Guigal. You do not want to miss this great opportunity so reserve your table now. Interesting, right? Share with your …

View Post

Invitation to discover the « New insights into cerebellar disorders »

In News Archives by ARSACS

Opportunity to meet Dr. Esther Becker from University of Oxford guest speaker at the NeuroForum 2019 conference and find out the «New insights into cerebellar disorders». The conference, organised by the Axe NeuroSciences, Centre de Recherche du CHU de Québec, will be held on Thursday 25,2019 at 11:00am at the LOEX site HEJ (Local R-138) and projected at the Amphithéâtre …

View Post

SacsR272C missense homozygous mice develop an ataxia phenotype

In News Archives by ARSACS

The research of Dr. Roxanne Larivière and her team supports that Sacs missense mutation largely leads to loss of Sacsin fucntion. SacsR272C missense homozygous mice develop an ataxia phenotype published in the Molecular Brain. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis:

View Post

Next Board meeting: June 5, 2019

In News Archives by ARSACS

The next meeting of the Board of the Ataxia Charlevoix-Saguenay Foundation will be held in Montreal on Wednesday June 5,2019. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis:

View Post

Dr. Maltecca expands her research

In News Archives by ARSACS

In addition to evaluating a post-symptomatic treatment on Sacs mice with an identified drug, Dr. Maltecca is also conducting a pre-symptomatic treatment to evaluate if such a drug can stop the neurodegeneration associated with ARSACS. Such results will be available at the end of this summer. Her work is also aimed at understanding how the drug could offer neuroprotection in …

View Post

Dr. McKinney’s research on ARSACS cells

In News Archives by ARSACS

Dr. Anne McKinney from McGill University describes her ARSACS research project focusing on how the cells of ARSACS patients communicate together and how some drugs could have an impact on the cells. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis: